12:00 AM
 | 
Jun 04, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Finibax regulatory update

Shionogi said it received Japanese approval to extend the indication for IV Finibax doripenem to include pediatric use, as well as the treatment of purulent meningitis....

Read the full 106 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >